SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001047469-18-003544
Filing Date
2018-05-07
Accepted
2018-05-07 17:08:27
Documents
6
Effectiveness Date
2018-05-07

Document Format Files

Seq Description Document Type Size
1 DEFR14A a2235635zdefr14a.htm DEFR14A 335209
2 G251456.JPG g251456.jpg GRAPHIC 8929
3 G104549.JPG g104549.jpg GRAPHIC 4023
4 G249170.JPG g249170.jpg GRAPHIC 4912
5 G130422BGI001.GIF g130422bgi001.gif GRAPHIC 105969
6 G130422BGI002.GIF g130422bgi002.gif GRAPHIC 108806
  Complete submission text file 0001047469-18-003544.txt   657178
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-37926 | Film No.: 18812106
SIC: 2834 Pharmaceutical Preparations